Skip to main content
Earnings Labs
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. (STOK) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$30.03

+2.26%

Mkt Cap $1.77B

EPS — Estimate vs Actual

Quarterly History

Q1 2026

Mar 16, 2026

$5.83M$1.40M-75.97%-$0.75-$0.97-29.33%
Q4 2025

Nov 4, 2025

$4.56M$10.63M+133.39%-$0.54-$0.65-20.37%
Q3 2025

Aug 12, 2025

$5.36M$13.82M+157.99%-$0.57-$0.40+29.82%
Q2 2025

May 13, 2025

$31.51M$158.57M+403.19%-$0.37$1.90+613.51%
Q1 2025

Mar 18, 2025

$3.86M$22.61M+485.85%-$0.51-$0.18+64.71%
Q4 2024

Nov 5, 2024

$4.20M$4.89M+16.52%-$0.52-$0.47+9.62%
Q3 2024

Aug 7, 2024

$3.26M$4.83M+48.19%-$0.57-$0.46+19.30%
Q2 2024

May 6, 2024

$3.21M$4.22M+31.34%-$0.60-$0.57+5.00%
Q1 2024

Mar 25, 2024

$3.25M$2.80M-13.78%-$0.62-$0.60+3.23%
Q4 2023

Nov 7, 2023

$3.25M$3.31M+1.78%-$0.65-$0.55+15.38%
Q3 2023

Aug 7, 2023

$3.17M$2.48M-21.74%-$0.65-$0.69-6.15%
Q2 2023

May 4, 2023

$3.00M$5.15M+71.73%-$0.70-$0.53+24.29%
Q1 2023

Mar 6, 2023

$2.86M$3.27M+14.19%-$0.72-$0.65+9.72%
Q4 2022

Nov 14, 2022

$2.72M$2.90M+6.71%-$0.69-$0.66+4.35%
Q3 2022

Aug 8, 2022

$2.64M$3.23M+22.36%-$0.70-$0.63+10.00%
Q2 2022

May 10, 2022

$50.00M$3.00M-94.00%$0.61-$0.66-208.20%
Q1 2022

Mar 10, 2022

-$0.62-$0.66-6.45%
Q4 2021

Nov 8, 2021

-$0.58-$0.61-5.17%
Q3 2021

Aug 10, 2021

-$0.49-$0.60-22.45%
Q2 2021

May 10, 2021

-$0.44-$0.46-4.55%
Q1 2021

Mar 9, 2021

-$0.43-$0.42+2.33%
Q4 2020

Nov 12, 2020

-$0.42-$0.41+2.38%
Q3 2020

Aug 10, 2020

-$0.36-$0.39-8.33%
Q2 2020

May 15, 2020

-$0.37-$0.34+8.11%
Q1 2020

Feb 24, 2020

-$0.31-$0.09+70.97%
Q4 2019

Nov 12, 2019

-$0.29-$0.26+10.34%
Q3 2019

Aug 14, 2019

-$0.96-$1.54-60.42%
Q2 2019

Jun 19, 2019

-$0.18
Q1 2019

Mar 31, 2019

-$0.19
Q3 2018

Sep 30, 2018

-$0.14
Q2 2018

Jun 30, 2018

-$0.13
Q1 2018

Mar 31, 2018

-$0.08